Lupin
-
Franchise India Bureau Nov 26 2018 - 1 min readLupin, India's third-largest drugmaker, has introduced 'ANYA', a chatbot designed to provide medically verified information for health-related queries. 'ANYA' is the first bot of its kind to be launched in the country for disease awareness. The chatbot aims to answer patient queries related to ailments. Initially, ANYA will address queries related to diabetes. This launch is Lupin’s ...
-
Franchise India Bureau Jul 30 2018 - 1 min readUS based Drug maker Lupin has received a go ahead signal from European Directorate for the Quality of Medicines (EDQM) for its Mandideep facility in Madhya Pradesh. According to Lupin, the facility inspected by EDQM in March this. "The inspection was focused on the application for certificate of suitability for the dossier of Cefaclor along with ...
-
Franchise India Bureau May 31 2018 - 1 min readMumbai based Pharmacy company has announced the appointment of Nicholas Hart as the head of company's specialty business. Mr Hart joins as President of this division and will lead Lupin’s Specialty brand business growth strategy and profit and loss. With over 25 years of specialty business, strategic and commercial operations experience ...
-
Franchise India Bureau May 14 2018 - 1 min readPharma major Lupin has confirmed the completion of the inspection by US health regulator for its Nagpur facility without making any observations. In a BSE filing, Lupin "announced the successful completion of an inspection carried out by the United States Food and Drug Administration (USFDA) at its Nagpur facility. The inspection ...
-
Franchise India Bureau Apr 06 2018 - 1 min readDrug firm Lupin has confirmed to have received an Establishment Inspection Report (EIR) from the US health regulator for its Pithampur, Unit 1 manufacturing facility in Madhya Pradesh. The inspection was conducted in July 2017, it said in a BSE filing. USFDA gives EIR on the closure of inspection ...